Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
Multiple Sclerosis International
|
March 25, 2015
Disease-modifying drugs reduce cortical lesion accumulation and atrophy progression in relapsing-remitting multiple sclerosis: results from a 48-month extension study
Francesca Rinaldi, Paola Perini, Matteo Atzori, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
June 8, 2026
Acute symptomatic seizures after accidental intrathecal lidocaine administration: A case series
Luciano Pellegrino, Giulia Bruschi, Rossana Ragone, et al.
Multiple Sclerosis International
|
October 12, 2012
Cortical Pathology in RRMS: Taking a Cue from Four Sisters
Massimiliano Calabrese, Dario Seppi, Eleonora Cocco, et al.
Journal of Neuroimmunology
|
March 25, 2014
Cerebrospinal fluid IL-1β correlates with cortical pathology load in multiple sclerosis at clinical onset
Dario Seppi, Marco Puthenparampil, Lisa Federle, et al.
Radiology
|
October 28, 2011
Cortical diffusion-tensor imaging abnormalities in multiple sclerosis: a 3-year longitudinal study
Massimiliano Calabrese, Francesca Rinaldi, Dario Seppi, et al.
Plos One
|
October 19, 2017
Enlarged Virchow Robin spaces associate with cognitive decline in multiple sclerosis
Alice Favaretto, Andrea Lazzarotto, Alice Riccardi, et al.
Frontiers in Neuroscience
|
June 24, 2024
Characterization of antiseizure medications effects on the EEG neurodynamic by fractal dimension
Camillo Porcaro, Dario Seppi, Giovanni Pellegrino, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
June 16, 2010
No evidence of JC virus reactivation in natalizumab treated multiple sclerosis patients: an 18 month follow-up study
Luciano Rinaldi, Francesca Rinaldi, Paola Perini, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
Multiple Sclerosis International
|
March 25, 2015
Disease-modifying drugs reduce cortical lesion accumulation and atrophy progression in relapsing-remitting multiple sclerosis: results from a 48-month extension study
Francesca Rinaldi, Paola Perini, Matteo Atzori, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
June 8, 2026
Acute symptomatic seizures after accidental intrathecal lidocaine administration: A case series
Luciano Pellegrino, Giulia Bruschi, Rossana Ragone, et al.
Multiple Sclerosis International
|
October 12, 2012
Cortical Pathology in RRMS: Taking a Cue from Four Sisters
Massimiliano Calabrese, Dario Seppi, Eleonora Cocco, et al.
Journal of Neuroimmunology
|
March 25, 2014
Cerebrospinal fluid IL-1β correlates with cortical pathology load in multiple sclerosis at clinical onset
Dario Seppi, Marco Puthenparampil, Lisa Federle, et al.
Radiology
|
October 28, 2011
Cortical diffusion-tensor imaging abnormalities in multiple sclerosis: a 3-year longitudinal study
Massimiliano Calabrese, Francesca Rinaldi, Dario Seppi, et al.
Plos One
|
October 19, 2017
Enlarged Virchow Robin spaces associate with cognitive decline in multiple sclerosis
Alice Favaretto, Andrea Lazzarotto, Alice Riccardi, et al.
Frontiers in Neuroscience
|
June 24, 2024
Characterization of antiseizure medications effects on the EEG neurodynamic by fractal dimension
Camillo Porcaro, Dario Seppi, Giovanni Pellegrino, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
June 16, 2010
No evidence of JC virus reactivation in natalizumab treated multiple sclerosis patients: an 18 month follow-up study
Luciano Rinaldi, Francesca Rinaldi, Paola Perini, et al.
Page
of 1